FDA OKs Pfizer COVID Booster for 65 and Over, Those at High Risk FDA OKs Pfizer COVID Booster for 65 and Over, Those at High Risk

The FDA has taken its advisory board ' s recommendations and approved a booster for Pfizer ' s mRNA vaccine for only a certain segment of the adult population.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news